| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Xencor, Inc. (XNCR) has 8 insiders with recent SEC Form 4 filings, including 23 buys and 1 sell. XNCR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 477.3K | $6.69M | - | |
| VP | 242.9K | $3.40M | - | |
| Dir | 110.4K | $1.55M | - | |
| CFO | 75.9K | $1.06M | - | |
| Dir | 15.5K | $217.8K | -5,064 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 16, 2018 | Foster Paul A | Chief Medical Officer | Sale+OE | 5,000 | $25.01 | $125,050.00 | -67.4% | |
| Dec 14, 2017 | Stafford John S III | 10% Owner | Buy | 9,215 | $20.76 | $191,279.80 | - | |
| Nov 28, 2017 | Stafford John S III | 10% Owner | Buy | 15,374 | $19.86 | $305,274.15 | +0.1% | |
| Nov 10, 2017 | Stafford John S III | 10% Owner | Buy | 41,823 | $19.91 | $832,607.69 | +0.3% | |
| Nov 7, 2017 | Stafford John S III | 10% Owner | Buy | 27,809 | $19.85 | $551,941.80 | +0.2% | |
| Nov 2, 2017 | Stafford John S III | 10% Owner | Buy | 50,000 | $19.58 | $979,036.40 | +0.3% | |
| Oct 27, 2017 | Stafford John S III | 10% Owner | Buy | 150,000 | $19.81 | $2,970,892.43 | +1.0% | |
| Aug 22, 2017 | Stafford John S III | 10% Owner | Buy | 41,016 | $19.69 | $807,590.84 | +0.4% | |
| Aug 18, 2017 | Stafford John S III | 10% Owner | Buy | 147,535 | $20.39 | $3,008,406.28 | +1.0% | |
| Aug 11, 2017 | Stafford John S III | 10% Owner | Buy | 27,000 | $21.13 | $570,490.00 | +0.3% |